My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Using a drug facts box to communicate drug benefits and harms: two randomized trials.

    Schwartz LM, Woloshin S, Welch HG.

    Ann Intern Med. 2009 Apr 21;150(8):516-27. Epub 2009 Feb 16.PMID: 19221371 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The drug facts box: providing consumers with simple tabular data on drug benefit and harm.

    Schwartz LM, Woloshin S, Welch HG.

    Med Decis Making. 2007 Sep-Oct;27(5):655-62. Epub 2007 Sep 14.PMID: 17873258 [PubMed - indexed for MEDLINE]Related articles

    3.

    The causes and effects of socio-demographic exclusions from clinical trials.

    Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

    Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.PMID: 16181564 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The value of benefit data in direct-to-consumer drug ads.

    Woloshin S, Schwartz LM, Welch HG.

    Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-234-45.PMID: 15452006 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.

    Saw J, Steinhubl SR, Berger PB, Kereiakes DJ, Serebruany VL, Brennan D, Topol EJ; Clopidogrel for the Reduction of Events During Observation Investigators.

    Circulation. 2003 Aug 26;108(8):921-4. Epub 2003 Aug 18.PMID: 12925453 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.

    Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, Christianson TJ, Mullan RJ, Smith SA.

    Arch Intern Med. 2007 May 28;167(10):1076-82.PMID: 17533211 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

    van Pinxteren B, Numans ME, Bonis PA, Lau J.

    Cochrane Database Syst Rev. 2001;(4):CD002095. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD002095. PMID: 11687139 [PubMed - indexed for MEDLINE]Related articles

    8.

    Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

    van Pinxteren B, Numans ME, Bonis PA, Lau J.

    Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002095. Review. Update in: Cochrane Database Syst Rev. 2006;3:CD002095. PMID: 15495027 [PubMed - indexed for MEDLINE]Related articles

    9.

    Single antiplatelet therapy for patients with previous gastrointestinal bleeds.

    Gellatly RM, Ackman ML.

    Ann Pharmacother. 2008 Jun;42(6):836-40. Epub 2008 Apr 15.PMID: 18413689 [PubMed - indexed for MEDLINE]Related articles

    10.

    Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

    Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

    Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.PMID: 18021578 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study.

    Jacobson TA, Gutkin SW, Harper CR.

    Curr Med Res Opin. 2006 Jun;22(6):1065-73.PMID: 16846539 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program.

    Stockl KM, Tjioe D, Gong S, Stroup J, Harada AS, Lew HC.

    J Manag Care Pharm. 2008 Jul-Aug;14(6):532-40.PMID: 18693777 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

    van Pinxteren B, Numans ME, Bonis PA, Lau J.

    Cochrane Database Syst Rev. 2000;(2):CD002095. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD002095. PMID: 10796857 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

    Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

    Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.PMID: 15461876 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The effectiveness of a primer to help people understand risk: two randomized trials in distinct populations.

    Woloshin S, Schwartz LM, Welch HG.

    Ann Intern Med. 2007 Feb 20;146(4):256-65.PMID: 17310049 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial.

    Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM; FASTER Investigators.

    Lancet Neurol. 2007 Nov;6(11):961-9. Epub 2007 Oct 10.PMID: 17931979 [PubMed - indexed for MEDLINE]Related articles

    17.

    Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events.

    Caro JJ, Migliaccio-Walle K.

    Am J Med. 1999 Dec;107(6):568-72.PMID: 10625025 [PubMed - indexed for MEDLINE]Related articles

    18.

    Communicating drug benefits and risks effectively: there must be a better way.

    Avorn J, Shrank WH.

    Ann Intern Med. 2009 Apr 21;150(8):563-4. Epub 2009 Feb 24. No abstract available. PMID: 19240226 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A systematic review and economic evaluation of statins for the prevention of coronary events.

    Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

    Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.PMID: 17408535 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.

    Saw J, Brennan DM, Steinhubl SR, Bhatt DL, Mak KH, Fox K, Topol EJ; CHARISMA Investigators.

    J Am Coll Cardiol. 2007 Jul 24;50(4):291-5. Epub 2007 Jul 10.PMID: 17659194 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity